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Synthesis and characterization of conjugate 1 and intermediates 
 
Conjugate 1 of [Rh(phen)(chrysi)(bpy)]3+ tethered to an aniline mustard was prepared in 
a thirdteen step sequence as outlined in Schemes S1 to S4.  
[Rh(phen)(chrysi)(NH3)2]3+ 2 was synthesized in four steps from rhodium trichloride, 
phenanthroline, and 5,6-chrysenequinone, and purified as described by Mürner, Jack-
son, and Barton (Scheme S1).[1] 
The synthesis of the aminoalkyl-functionalized bipyridine 6 is shown in Scheme S2. The 
mono-anion of 4,4'-dimethylbipyridine, obtained by deprotonation of 3 with one equiva-
lent of freshly prepared lithium diisopropylamine, was reacted with an excess of 1,6-
dibromohexane under carefully controlled conditions.[2, 3] After aqueous workup and col-
umn chromatography on silica with a gradient of dichloromethane and diethylether, 4-(7-
bromoheptyl)-4'-methylbipyridine 4 was obtained in 58 % yield. This was converted to 
phthalimide 5 in almost quantitative yield by reaction with potassium phthalimide fol-
lowed by cleavage to 4-(7-aminoheptyl)-4'-methylbipyridine 6 with hydrazine monohy-
drate in methanol.[4] 
Aminoalkyl-substituted bipyridine 6 was then reacted with [Rh(phen)(chrysi)(NH3)2]3+ 2 in 
anhydrous acetonitrile at elevated temperature to give [Rh(phen)(chrysi)(bipy#)]3+ 7 in 43 
% yield after purification on Sephadex SP C25 (Scheme S3). 
The aniline mustard 12 was prepared in four steps from 4-aminophenol 8 as outlined in 
Scheme S4.[5-7] The starting material was reacted with bromoacetic acid ethyl ester and 
separated from other alkylation products by column chromatography on silica to give 9. 
This compound was then reacted with oxirane to give (4-(N,N-bis(2-hydroxy-ethyl)-
phenoxy)acetic acid ester 10. The hydroxy groups were substituted by chlorides upon 
treatment with phosphoroxytrichloride in benzene to give 11 and the ester protective 
group then removed under acidic conditions to yield 12. 
Conjugate 1 was then prepared by coupling of 7 with 12 in anhydrous dimethylforma-
mide in the presence of EDAC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) and 
HOBt (1-hydroxybenzotriazol) as shown in Scheme 1 and finally purified by semi-
preparative HPLC. 
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Scheme S1. Synthesis of tris-heteroleptic rhodium complexes.  
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Scheme S2. Synthesis of an aminoalkyl-functionalized bipyridine ligand. 
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Scheme S3. Introduction of the aminoalkyl-substituted bipyridine to the rhodium-
chrysenequinone diimine complex.  
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Scheme S4. Synthesis of a carboxy-functionalized aniline mustard.  
 
NH2
OH
Br COOEt
NH2
O
COOEt
O
N
O
COOEt
HO OH
N
O
COOEt
Cl Cl
POCl3
N
O
COOH
Cl Cl
conc. HCl
28 % 23 %
64 % 60 %
8 9 10
11 12  
 
S7 
Synthetic procedures and characterization 
 
4-(7-Bromoheptyl)-4'-methylbipyridine 4 
 
Anhydrous tetrahydrofuran (25 ml) was placed in a dry Schlenk bottle under argon and 
cooled to -78 °C with an acetone/dry ice mixture. Then diisopropylamine (4.6 ml, 32.8 
mmol) was added via syringe followed by n-butyllithium (15 % solution in hexane, 17.2 
ml, 27.4 mmol) to give a slightly yellow solution which was kept at -78 °C. In a separate 
Schleck bottle, 4,4'-dimethylbipyridine (5.0 g, 27.2 mmol) was dissolved in anhydrous 
tetrahydrofuran (150 ml), precooled to -78 °C and then added to the former solution. The 
mixture, which turned deep brown, was stirred at that temperature for 1 h and then al-
lowed to warm to 0 °C by placing in an ice bath. In another Schlenk bottle, 1,6-
dibromohexane (20 ml, 51.2 mmol) was dissolved in anhydrous tetrahydrofuran (20 ml) 
at room temperature and then added to the former solution at once(!). The mixture first 
turned blue but the color changed to yellow within 1.5 h hours, after which the reaction 
was quenched by addition of water (100 ml). After stirring for 30 min, the pH was ad-
justed to pH = 5 and the mixture left to stand overnight. The yellow organic phase was 
separated, the aqueous phase extracted with ether (100 ml) and dichloromethan (2x 100 
ml), and the combined organic phases washed with 5 M sodium chloride, dried over 
magnesium sulfate, and the solvent removed in vacuo at room temperature(!). The 
slightly yellow oil obtained was purified by column chromatography on silica first with di-
chloromethane as the eluent to remove excess 1,6-dibromohexane, and then with a 
gradient of dichloromethane/ether (100:0 → 0:100). After removal of the solvent, the 
product was obtained as a white solid (5.48 g, 15.78 mmol, 58.0 %). 1H NMR (CDCl3, 
300 MHz): δ = 8.55 (t, J = 4.8 Hz, 2H), 8.23 (m, 2H), 7.13 (d, J = 4.8 Hz, 2H), 3.40 (t, J = 
6.7 Hz, 2H), 2.69 (t, J = 7.8 Hz, 2H), 2.44 (s, 3H), 1.84 (m, 2H), 1.70 (m, 2H), 1.37 (m, 
6H); MS(ESIpos): 369 (M+Na), 347 (M+H), 267 (M-Br). 
 
4-(7-phthalimidoheptyl)-4'-methylbipyridine 5 
 
4-(7-Bromoheptyl)-4'-methylbipyridine 4 (0.70 g, 2.00 mmol) was dissolved in anhydrous 
dimethylformamide (125 ml) and solid potassium phthalimide (0.45 g, 2.40 mmol) was 
added to the slightly yellow solution. After stirring for 90.5 h, the solution was diluted with 
chloroform (80 ml) and then poured into water (250 ml). The phases were separated and 
the aqueous phase extracted with chloroform (2x 100 ml). The combined organic phases 
were washed with 0.2 M sodium hydroxide (100 ml), water, and brine, dried over mag-
nesium sulfate, and the solvent removed to give the product as a colorless oil which so-
lidified to a white solid upon standing (0.81 g, 1.96 mmol, 98.0 %). 1H NMR (CDCl3, 300 
MHz): δ = 8.53 (m, 2H), 8.21 (m, 2H), 7.83 (m, 2H), 7.69 (m, 2H), 7.12 (m, 2H), 3.67 (t, J 
= 7.2 Hz, 2H), 2.67 (t, J = 7.8 Hz, 2H), 2.43 (s, 3H), 1.66 (m, 4H), 1.36 (m, 6H); 
MS(ESIpos): 414 (M+H), 436 (M+Na). 
 
4-(7-aminoheptyl)-4'-methylbipyridine 6 
 
Phthalimide 5 (0.81 g, 1.96 mmol) was dissolved in methanol (50 ml) by heating to 70 °C 
to give a colorless solution. Then hydrazine monohydrate (0.2 ml, 4.1 mmol) was added 
and the reaction mixture stirred at 70 °C for 19 h. The solvent was removed and 6 M hy-
drochloric acid (100 ml) added to the white solid obtained. The suspension was ex-
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tracted with chloroform, the organic phase washed with 6 M hydrochloric acid (60 ml), 
and the combined aqueous phases then adjusted to pH = 8 with 5 M sodium hydroxide. 
The aqueous phase was extracted with chloroform and ether, the combined organic 
phases dried over magnesium sulfate and evaporated to dryness to give the product as 
a white solid (420 mg, 1.48 mmol, 76 %). 1H NMR (CDCl3, 300 MHz): δ = 8.54 (t, J = 4.5 
Hz, 2H), 8.21 (m, 2H), 7.13 (d, J = 4.8 Hz, 2H), 2.68 (m, 4H), 2.43 (s, 3H), 1.85 (s, 2H), 
1.70 (m, 4H), 1.39 (m, 6H); MS (ESIpos): 284 (M+H). 
 
[Rh(phen)(chrysi)(bipy#)]Cl3 7 
 
4-(7-aminoheptyl)-4'-methylbipyridine 6 (160.0 mg, 0.56 mmol) was dissolved in anhy-
drous acetonitrile (35 ml) and then [Rh(phen)(chrysi)(NH3)4]Cl3 2 (226.6 mg, 0.33 mmol), 
dissolved in 25 ml of the same solvent with sonication, was added to the former solution. 
The mixture was heated to reflux under argon for 19.5 h, cooled to room temperature, 
and the solvent removed to give a deep brown solid. The solid was dissolved in a mini-
mum amount of 0.05 M magnesium chloride and methanol and then loaded onto a col-
umn of Sephadex SP C25 (20x4 cm) pre-equilibrated with 0.05 M magnesium chloride 
and the product eluted with a gradient of 0.05 → 0.5 M magnesium chloride. All magne-
sium chloride solutions were acidified with a drop of hydrochloric acid. The main fraction 
was loaded on a C18 Waters SepPak (10 g) which was washed with cupious amount of 
water, and the product then eluted with acetonitrile containing a drop of trifluoroacetic 
acid. In order to obtain a more pure product (> 98 % from HPLC), the purification proce-
dure was repeated once. After removal of the solvent in a stream of air and drying in 
vacuo, the product was obtained as a red-brown solid (131.4 mg, 0.13 mmol, 39.4 %). 
MS (ESIpos): 820 (M+-3Cl-2H), 410 (M2+-3Cl-H); UV/Vis (water): 212, 264, 298 (sh), 312 
(sh), 398 (6200) nm (l mol-1 cm-1); HPLC (100:0 →30:70 water/acetonitrile over 50 min) 
> 98 %. 
 
(4-Aminophenoxy)acetic acid ethyl ester 9 
 
4-Aminophenol 8 (20.0 g, 183.3 mmol) was dissolved in ice-cold degassed anhydrous 
dimethylformamide (250 ml) under argon and then solid sodium hydride (55 - 65 % in oil, 
7.6 g, 190 mmol) was added in small portions. The solution was stirred at 0 °C for 30 
min after which it had turned deep red-brown. Then bromoacetic acid ethyl ester (20.2 
ml, 182.2 mmol) was slowly added at 0 °C via syringe and the resulting mixture stirred at 
room temperature overnight. After removal of the solvent, the resulting orange gum was 
dissolved in a mixture of ethylacetate and water (250 ml, 1:1), the organic phase sepa-
rated, the aqueous phase extracted with ethyl acetate (2x 100 ml), the combined organic 
phases washed with sodium hydrogencarbonate, brine, and water, drived over magne-
sium sulfate and the solvent removed. The resulting brown oil was purified twice by col-
umn chromatography on silica with chloroform/methanol (9:1) as the eluent to give the 
product as an orange oil which slowly solidified (9.83 g, 50.4 mmol, 27.5 %). 1H NMR 
(CDCl3, 300 MHz): δ = 6.76 (d, J = 9.3 Hz, 2H), 6.62 (d, J = 9.0 Hz, 2H), 4.53 (s, 2H), 
4.25 (q, J = 7.2 Hz, 2H), 1.29 (t, J = 7.2 Hz, 3H); MS (ESIpos): 196 (M+H), 218 (M+Na). 
 
S9 
(4-Bis(2-hydroxyethyl)aminophenoxy)acetic acid ethyl ester 10 
 
(4-Aminophenoxy)acetic acid ethyl ester 9 (7.89 g, 40.4 mmol) was dissolved in a de-
gassed mixture of acetic acid and water (35 ml, 1:1) under argon to give a orange-to-red 
solution which was cooled to 0 °C. Oxirane (9.10 g, 206.6 mmol) was condensed into a 
separate Schlenk bottle immersed in acetone/dry ice and then added with a syringe pre-
cooled to -20 °C to the former solution. The mixture was allowed to warm to room tem-
perature while stirring under argon for 18.5 h and the deep brown solution then concen-
trated in vacuo at < 40 °C. Water (25 ml) was added to the resulting oily material and the 
product extracted with ether (4x 100 ml). The combined organic phases were carefully 
washed neutral with 2 M sodium hydrogencarbonate (100 ml) in a large separation fun-
nel (strong effervescence!) followed by water, dried over magnesium sulfate and the sol-
vent then removed at < 40 °C. The resulting material was twice recrystallized from tolu-
ene/hexanes (300 ml, 1:1) to remove some brown oil and then purified by column chro-
matography on silica with chloroform/methanol (9:1) as the eluent. The product was ob-
tained as a slightly pinkish oil which very slowly solidified to a white solid (2.58 g, 9.1 
mmol, 22.5 %). 1H NMR (CDCl3, 300 MHz): δ = 6.82 (d, J = 9.0 Hz Hz, 2H), 6.66 (d, J = 
9.0 Hz, 2H), 4.53 (s, 2H), 4.24 (q, J = 7.1 Hz, 2H), 3.76 (t, J = 5.0 Hz, 4H), 3.45 (t, J = 
4.8 Hz, 4H), 1.28 (t, J = 7.1 Hz, 3H); MS (ESIpos): 284 (M+H), 306 (M+Na). 
 
(4-Bis(2-chloroethyl)aminophenoxy)acetic acid ethyl ester 11 
 
(4-Bis(2-hydroxyethyl)aminophenoxy)acetic acid ethyl ester 10 (0.81 g, 2.86 mmol) was 
dissolved in anhydrous benzene (10 ml) and then phosphoroxy trichloride (0.8 ml, 8.58 
mmol) was added via syringe followed by heating to 100-110 °C for 1 h. Afterwards, the 
solution was poured on ice, the organic phase separated, dried over magnesium sulfate, 
and shaken with activated alumina. After removal of the solvent, the product was ob-
tained as a colorless oil which solidified to a white solid (0.58 g, 1.81 mmol, 63.3 %). 1H 
NMR (CDCl3, 300 MHz): δ = 6.84 (d, J = 9.0 Hz, 2H), 6.62 (d, J = 9.3 Hz Hz, 2H), 4.52 
(s, 2H), 4.24 (q, J = 7.2 Hz, 2H), 3.59 (m, 8H), 1.27 (t, J = 7.2 Hz, 3H); MS (ESIpos): 320 
(M+H). 
 
(4-Bis(2-chloroethyl)aminophenoxy)acetic acid 12 
 
(4-Bis(2-chloroethyl)aminophenoxy)acetic acid ethyl ester 11 (0.62 g, 1.94 mmol) was 
dissolved in concentrated hydrochloric acid (10 ml), heated to reflux for 1 h and cooled 
to room temperature. After addition of water (50 ml), the product was extracted into di-
ethylether (4x 50 ml), the combined organic phases wahsed with water, dried over mag-
nesium sulfate, and the solvent removed to give a white solid (0.34 g, 1.16 mmol, 59.8 
%). 1H NMR (CDCl3, 300 MHz): δ = 6.87 (d, J = 9.0 Hz, 2H), 6.65 (d, J = 9.3 Hz, 2H), 
4.60 (s, 2H), 3.62 (m, 8H); MS (ESIpos): 292 (M+H). 
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[Rh(phen)(chrysi)(bipy)]Cl3 1 
 
[Rh(phen)(chrysi)(bipy#)]Cl3 7 (5.8 mg, 6.2 µmol) was dissolved in anhydrous dimethyl-
formamide under argon to give a bright orange solution. Then, (4-Bis(2-
chloroethyl)aminophenoxy)acetic acid 12 (2.0 mg, 6.8 µmol) was added as a solid fol-
lowed by HOBt (1-hydroxybenzotriazol, 2.1 mg, 15.5 µmol). Finally, EDAC (1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide, 5 µl, 36.7 µmol) was added and the solution stirred 
at room temperature for 2.5 h. Then, water (5 ml) was added and the resulting solution 
loaded on a C18 Waters SepPak (5 g) which was washed with cupious amount of water. 
The product was eluted with acetonitrile containing a drop of trifluoroacetic acid, the sol-
vent removed in a stream of air and the resulting red-brown solid stored at -80 °C. The 
product was then dissolved in 600 µl of acetonitrile and purified by semi-preparative 
HPLC on a HP/Agilent 1100 system with a Dynamax 300 Ǻ C1 column using a gradient 
of 0.5 % trifluoroacetic acid in water and acetonitrile (100:0 → 30:70 over 60 min). The 
main peak was collected, the solution frozen at -80 °C, and the product lyophilized to 
dryness. The resulting red-brown solid was dissolved in water (2 ml) and kept at -80 °C. 
Aliquots were taken from the thawed solution and diluted as needed. MS (ESIpos): 1093 
(M+-3Cl-2H). 
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